John Didsbury
Vorstandsvorsitzender bei T3D Therapeutics, Inc.
Aktive Positionen von John Didsbury
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | Vorstandsvorsitzender | 01.01.2013 | - |
Vorsitzender | - | - | |
Präsident | - | - |
Karriereverlauf von John Didsbury
Ehemalige bekannte Positionen von John Didsbury
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DARA BIOSCIENCES INC | Geschäftsführer | 12.02.2008 | 06.02.2009 |
Technik-/Wissenschafts-/F&E-Leiter | 12.02.2008 | 06.02.2009 | |
Präsident | 12.02.2008 | 06.02.2009 | |
DARA BioSciences, Inc. /Old/
DARA BioSciences, Inc. /Old/ Pharmaceuticals: MajorHealth Technology DARA BioSciences, Inc. develops therapeutic and medical technologies and devices. It also provides treatment for metabolic diseases and central nervous system disorders . The company was founded by Steve Gorlin in July, 2002 and is headquartered in Raleigh, NC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2005 | 12.02.2008 |
Nuada Pharmaceuticals, Inc.
Nuada Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuada Pharmaceuticals, Inc. operates as a pharmaceutical company. The private company is based in Durham, NC. | Präsident | 01.01.2000 | 01.01.2005 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 01.01.1995 | 01.01.2002 |
Ausbildung von John Didsbury
University of Connecticut | Undergraduate Degree |
University of Vermont | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Kanada | 2 |
Operativ
President | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
DARA BioSciences, Inc. /Old/
DARA BioSciences, Inc. /Old/ Pharmaceuticals: MajorHealth Technology DARA BioSciences, Inc. develops therapeutic and medical technologies and devices. It also provides treatment for metabolic diseases and central nervous system disorders . The company was founded by Steve Gorlin in July, 2002 and is headquartered in Raleigh, NC. | Health Technology |
DARA BioSciences, Inc.
DARA BioSciences, Inc. Pharmaceuticals: MajorHealth Technology DARA BioSciences, Inc. is a pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care products. The company's product portfolio includes Soltamox, Gelclair, Bionect and KRN5500. Soltamox offers a choice to patients who prefer or need a liquid form of tamoxifen. Gelclair is an alcohol-free bioadherent oral rinse gel for rapid and effective relief of pain associated with oral mucositis caused by chemotherapy and radiation treatment. The company markets Bionect, a topical treatment for skin irritation and burns associated with radiation therapy, in U.S. oncology/radiology markets. DARA BioSciences was founded by Steven Gorlin on June 22, 2002 and is headquartered in Raleigh, NC. | Health Technology |
Nuada Pharmaceuticals, Inc.
Nuada Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuada Pharmaceuticals, Inc. operates as a pharmaceutical company. The private company is based in Durham, NC. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | Health Technology |
- Börse
- Insiders
- John Didsbury
- Erfahrung